Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment

test tubes

Cara Therapeutics starts drug development with Vifor Fresenius

Cara Therapeutics, a biopharmaceutical company, announced that it has licensed worldwide rights to commercialize KORSUVA injection for the treatment of chronic kidney disease-associated pruritus.

Evotec and Celgene started oncology partnership

Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.

Pharmoslavl will be able to produce over 30 tons of pharma substances a year

A key strategic objective of Russian drug manufacturers is to start production of their own substances. One of the most successful full-cycle sites operates in the Yaroslavl region. This new resear...

GC Pharma launched new company focused on novel vaccine development

GC Pharma, a South Korean biopharmaceutical company, announced the establishment of Curevo Inc. The newly established Seattle-based company's goal is to support GC Pharma's vaccine development activities.

WuXi Biologics starts cooperation with Bioasis to advance new brain cancer drug

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bioasis Technologies announ...

Most drugs developed in Russia are related to cancer treatment

In addition to development of medicinal products for treatment of various oncological diseases, other most common Russian developments include drugs for the treatment of infectious and inflammatory diseases, wounds, and burns.

Russian Ministry included the Kirov region biotech cluster in its register

The industrial cluster became the first in the region to have been included in the list of industrial clusters and specialized organizations of industrial clusters of the Ministry of Industry and Trade of Russia.

Emulate and AstraZeneca will jointly develop Organs-on-Chips technology

Emulate Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED.


Expert opinion